Nanox Announces Clinical and Educational Collaboration with Keiser University Featuring the Nanox.ARC
Nanox (NASDAQ:NNOX) has announced a strategic clinical and educational collaboration with Keiser University to deploy its advanced Nanox.ARC 3D digital tomosynthesis imaging system at the university's Sarasota Campus. The system will be used for training healthcare professionals and will be incorporated into Keiser's Radiologic Technology graduate program.
The Nanox.ARC features a proprietary digital X-ray source and cold cathode technology, providing enhanced 3D imaging capabilities. Clinical studies have demonstrated the system's improved sensitivity and specificity compared to traditional X-ray, while achieving reduced radiation exposure and shorter radiologist reading times compared to CT scans.
The collaboration with Keiser University, which has awarded approximately 100,000 degrees and operates 19 Florida campuses, aims to educate prospective users about the Nanox.ARC's clinical value and increase the usage of various clinical protocols for patient benefit.
Nanox (NASDAQ:NNOX) ha annunciato una collaborazione strategica clinica ed educativa con la Keiser University per implementare il suo avanzato sistema di tomosintesi digitale 3D Nanox.ARC nel campus di Sarasota dell'università. Il sistema sarà utilizzato per la formazione dei professionisti sanitari e sarà integrato nel programma di laurea in Tecnologia Radiologica di Keiser.
Il Nanox.ARC è dotato di una sorgente digitale a raggi X proprietaria e tecnologia a catodo freddo, offrendo capacità di imaging 3D migliorate. Studi clinici hanno dimostrato una maggiore sensibilità e specificità rispetto ai raggi X tradizionali, riducendo al contempo l'esposizione alle radiazioni e i tempi di lettura da parte dei radiologi rispetto alle scansioni TC.
La collaborazione con Keiser University, che ha conferito circa 100.000 lauree e gestisce 19 campus in Florida, mira a formare i futuri utilizzatori sul valore clinico del Nanox.ARC e a incrementare l'adozione di vari protocolli clinici a beneficio dei pazienti.
Nanox (NASDAQ:NNOX) ha anunciado una colaboración clínica y educativa estratégica con Keiser University para implementar su avanzado sistema de tomosíntesis digital 3D Nanox.ARC en el campus de Sarasota de la universidad. El sistema se utilizará para la formación de profesionales de la salud y se incorporará al programa de posgrado en Tecnología Radiológica de Keiser.
El Nanox.ARC cuenta con una fuente digital de rayos X patentada y tecnología de cátodo frío, que proporciona capacidades mejoradas de imagen 3D. Estudios clínicos han demostrado una mayor sensibilidad y especificidad en comparación con los rayos X tradicionales, mientras que se logra una reducción en la exposición a la radiación y en los tiempos de lectura por parte de los radiólogos en comparación con las tomografías computarizadas.
La colaboración con Keiser University, que ha otorgado aproximadamente 100,000 títulos y opera 19 campus en Florida, tiene como objetivo educar a los futuros usuarios sobre el valor clínico del Nanox.ARC e incrementar el uso de diversos protocolos clínicos en beneficio de los pacientes.
Nanox (NASDAQ:NNOX)는 Keiser University와 전략적 임상 및 교육 협력을 발표하여 대학의 Sarasota 캠퍼스에 첨단 Nanox.ARC 3D 디지털 토모신테시스 영상 시스템을 도입합니다. 이 시스템은 의료 전문가 교육에 사용되며 Keiser의 방사선 기술 대학원 프로그램에 통합될 예정입니다.
Nanox.ARC는 독자적인 디지털 X선 소스와 콜드 캐소드 기술을 특징으로 하며 향상된 3D 영상 기능을 제공합니다. 임상 연구에서 전통적인 X선에 비해 민감도와 특이도가 향상되었으며, CT 스캔과 비교해 방사선 노출 감소 및 방사선 전문의 판독 시간 단축을 달성했습니다.
약 10만 명의 학위를 수여하고 플로리다에 19개 캠퍼스를 운영하는 Keiser University와의 협력은 Nanox.ARC의 임상적 가치를 예비 사용자에게 교육하고 환자 혜택을 위한 다양한 임상 프로토콜 사용을 증대하는 것을 목표로 합니다.
Nanox (NASDAQ:NNOX) a annoncé une collaboration clinique et éducative stratégique avec l'université Keiser pour déployer son système avancé de tomosynthèse numérique 3D Nanox.ARC sur le campus de Sarasota de l'université. Ce système sera utilisé pour former les professionnels de santé et sera intégré au programme de maîtrise en technologie radiologique de Keiser.
Le Nanox.ARC dispose d'une source de rayons X numérique propriétaire et d'une technologie à cathode froide, offrant des capacités d'imagerie 3D améliorées. Des études cliniques ont démontré une sensibilité et une spécificité accrues par rapport aux rayons X traditionnels, tout en obtenant une réduction de l'exposition aux radiations et des temps de lecture par les radiologues comparativement aux scanners CT.
La collaboration avec Keiser University, qui a décerné environ 100 000 diplômes et gère 19 campus en Floride, vise à former les futurs utilisateurs sur la valeur clinique du Nanox.ARC et à accroître l'utilisation de divers protocoles cliniques au bénéfice des patients.
Nanox (NASDAQ:NNOX) hat eine strategische klinische und pädagogische Zusammenarbeit mit der Keiser University angekündigt, um sein fortschrittliches Nanox.ARC 3D digitales Tomosynthese-Bildgebungssystem auf dem Campus der Universität in Sarasota einzusetzen. Das System wird zur Ausbildung von Gesundheitsfachkräften genutzt und in das Radiologische Technologie-Studienprogramm von Keiser integriert.
Das Nanox.ARC verfügt über eine proprietäre digitale Röntgenquelle und Kaltkathodentechnologie, die verbesserte 3D-Bildgebung ermöglicht. Klinische Studien haben eine höhere Sensitivität und Spezifität im Vergleich zu herkömmlichen Röntgenaufnahmen gezeigt, während gleichzeitig die Strahlenbelastung reduziert und die Lesezeiten der Radiologen im Vergleich zu CT-Scans verkürzt werden.
Die Zusammenarbeit mit der Keiser University, die etwa 100.000 Abschlüsse vergeben und 19 Standorte in Florida betreiben, zielt darauf ab, potenzielle Anwender über den klinischen Wert des Nanox.ARC aufzuklären und die Nutzung verschiedener klinischer Protokolle zum Nutzen der Patienten zu erhöhen.
- None.
- None.
- Nanox.ARC delivers advanced 3D imaging with proprietary cold cathode technology
- Clinical studies show superior diagnostic performance to X-ray with reduced radiation exposure compared to CT
PETACH TIKVA, Israel, July 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced a clinical and educational collaboration with Keiser University, Florida’s largest private, non-profit university.
The Nanox.ARC, an advanced 3D digital tomosynthesis imaging system, will be deployed at Keiser University’s Sarasota Campus for training healthcare professionals, including live demonstrations and incorporation into Keiser University’s Radiologic Technology graduate program. Access to the Nanox.ARC will be available on campus for students, physicians, radiology technicians and local medical imaging providers, as part of efforts to educate prospective users about the Nanox.ARC’s clinical value and patient benefits, as well as increase the usage of the various clinical protocols and indications for patient benefit.
The Nanox.ARC features a proprietary digital X-ray source and advanced 3D imaging technology powered by a cold cathode, offering a more detailed, layered view of the body. In clinical studies, Nanox.ARC has been shown to improve the sensitivity and specificity of traditional X-ray, while reducing patient radiation exposure and radiologist reading times compared to CT.
Since 1977, Keiser University has awarded roughly 100,000 degrees to students throughout Florida, the United States, and internationally. The institution, headquartered in Fort Lauderdale with 19 Florida campuses, serves as an important provider of workforce talent in many of Florida’s targeted and emerging industries including healthcare and nursing.
Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox: “As one of Florida’s largest private, non-profit institutions and a partner with various healthcare providers in the region, Keiser University was an excellent fit to serve as the latest site of our ongoing deployment of the Nanox.ARC in the U.S. We look forward to working with Keiser and supporting the enhancement of their clinical educational program.”
Mr. Meltzer continued, “This partnership is the latest validation of Nanox’s end-to-end medical imaging solution and exemplifies our mission to drive the world's transition to preventive healthcare through innovative and accessible technology. By introducing our digital tomosynthesis platform, we're empowering the next generation of healthcare professionals with clinical insights that can improve patient care outcomes. Keiser University students will have a window to experience an innovative technology that delivers superior diagnostic accuracy not available in traditional X-ray, providing clinical insights which may improve early detection and diagnosis, combined with significantly lower radiation exposure than traditional CT scans.”
About Nanox
Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and proprietary digital X-ray source.
Nanox's vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI to enhance the efficiency of routine medical imaging technology and processes, in order to improve early detection and treatment and maintaining a clinically driven approach. The Nanox ecosystem includes Nanox.ARC – a multi-source digital tomosynthesis system that is cost-effective and user-friendly; Nanox.AI LTD – an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic diseases; Nanox.CLOUD – a cloud-based software platform that manages and stores data collected by Nanox devices, and provides users with tools for in-depth imaging analysis; Nanox.MARKETPLACE – a proprietary decentralized marketplace through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts, and a comprehensive teleradiology services platform. By improving early detection and treatment, Nanox aims to enhance better health outcomes worldwide. For more information, please visit www.nanox.vision
About Keiser University:
Keiser University is a private, independent, non-profit university serving nearly 20,000 students at 21 Florida campuses, online, and two international sites. Co-founded in in 1977 by Chancellor Arthur Keiser, Ph.D., and Evelyn Keiser, the university now offers over 100-degree programs, ranging from associate to doctoral levels. As a designated Hispanic-Serving Institution, Keiser University is a member of the Hispanic Association of Colleges and Universities. In 2025, it was ranked No. 22 in the U.S. for Social Mobility by U.S. News and World Report.
Forward-Looking Statements
This press release may contain forward-looking statements that are subject to risks and uncertainties. All statements that are not historical facts contained in this press release are forward-looking statements. Such statements include, but are not limited to, any statements relating to the initiation, timing, progress and results of the Company’s research and development, manufacturing, and commercialization activities with respect to its X-ray source technology and the Nanox.ARC, the ability to realize the expected benefits of its recent acquisitions and the projected business prospects of the Company and the acquired companies. In some cases, you can identify forward-looking statements by terminology such as “can,” “might,” “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “should,” “could,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. Forward-looking statements are based on information the Company has when those statements are made or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause actual results to differ materially from those currently anticipated include: risks related to (i) Nanox’s ability to complete development of the Nanox System; (ii) Nanox’s ability to successfully demonstrate the feasibility of its technology for commercial applications; (iii) Nanox’s expectations regarding the necessity of, timing of filing for, and receipt and maintenance of, regulatory clearances or approvals regarding its technology, the Nanox.ARC and Nanox.CLOUD from regulatory agencies worldwide and its ongoing compliance with applicable quality standards and regulatory requirements; (iv) Nanox’s ability to realize the anticipated benefits of the acquisitions, which may be affected by, among other things, competition, brand recognition, the ability of the acquired companies to grow and manage growth profitably and retain their key employees; (v) Nanox’s ability to enter into and maintain commercially reasonable arrangements with third-party manufacturers and suppliers to manufacture the Nanox.ARC; (vi) the market acceptance of the Nanox System and the proposed pay-per-scan business model; (vii) Nanox’s expectations regarding collaborations with third-parties and their potential benefits; (viii) Nanox’s ability to conduct business globally; (ix) changes in global, political, economic, business, competitive, market and regulatory forces; (x) risks related to the current war between Israel and Hamas, the war between Israel and Iran, and any worsening of the situation in Israel; (xi) risks related to business interruptions resulting from the COVID-19 pandemic or similar public health crises, among other things; and (xii) potential litigation associated with our transactions.
For a discussion of other risks and uncertainties, and other important factors, any of which could cause Nanox’s actual results to differ from those contained in the Forward-Looking Statements, see the section titled “Risk Factors” in Nanox’s Annual Report on Form 20-F for the year ended December 31, 2024, and subsequent filings with the U.S. Securities and Exchange Commission. The reader should not place undue reliance on any forward-looking statements included in this press release. Except as required by law, Nanox undertakes no obligation to update publicly any forward-looking statements after the date of this press release to conform these statements to actual results or to changes in the Company’s expectations.
Contacts
Media Contact:
Ben Shannon
ICR Healthcare
NanoxPR@icrinc.com
Investor Contact:
Mike Cavanaugh
ICR Healthcare
mike.cavanaugh@icrhealthcare.com
FAQ
What are the key features of the Nanox.ARC imaging system?
How does the Nanox.ARC's radiation exposure compare to traditional CT scans?
What is the purpose of Nanox's collaboration with Keiser University?
How will the Nanox.ARC deployment benefit Keiser University students?
What advantages does the Nanox.ARC offer over traditional imaging systems?
